C. Vitali

L. Pignataro, C. Vitali, M. Benazzo, 2018, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Management of primary Sjögren’s syndrome: recent developments and new classification criteria

C. Vitali, N. Del Papa, 2018, Therapeutic advances in musculoskeletal disease.

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

Rachel M. Brown, R. Jonsson, X. Mariette, 2016, Annals of the rheumatic diseases.

Pain in primary Sjögren's syndrome.

C. Vitali, N. Del Papa, 2015, Best practice & research. Clinical rheumatology.

Is it the time to adopt salivary gland ultrasonography as an alternative diagnostic tool for the classification of patients with Sjögren's syndrome? Comment on the article by Cornec et al.

F. Salaffi, M. Carotti, C. Vitali, 2013, Arthritis and rheumatism.

Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection

C. Vitali, 2011, Arthritis research & therapy.

N. Stahl, H. Spiera, D. Wallace, 2010 .

Immunopathologic diff erences of Sjögren ’ s syndrome versus sicca syndrome in HCV and HIV infection

C. Vitali, 2022 .

Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases.

P. Baglioni, S. Bombardieri, C. Vitali, 2010, Arthritis and rheumatism.

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19

R. Caporali, C. Vitali, N. Del Papa, 2020, Thrombosis Research.

Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone In Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension

O. Olivieri, C. Vitali, A. Ruzzenente, 2022, Biomedicines.

Cryoglobulins and immune complexes in essential mixed cryoglobulinemia

G. Pasero, S. Bombardieri, P. Migliorini, 1986, La Ricerca in clinica e in laboratorio.

Parotid sialography and minor salivary gland biopsy in the diagnosis of Sjögren's syndrome. A comparative study of 84 patients.

S. Bombardieri, C. Vitali, A. D'ascanio, 1988, The Journal of rheumatology.

Assessment oftheEuropean classification criteria forSjogren's syndrome inaseries ofclinically defined cases: results ofaprospective multicentre study

S. Bombardieri, C. Vitali, M. Tomšič, 1996 .

Traditional cardiovascular risk factors in primary Sjögren's syndrome--role of dyslipidaemia.

Y. Shoenfeld, C. Vitali, R. Gerli, 2006, Rheumatology.

Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement

G. Pasero, S. Bombardieri, C. Vitali, 1986, La Ricerca in clinica e in laboratorio.

Looking into the Future—The EULAR Disease Activity Scores: Toward a Consensual Evaluation of Primary Sjogren’s Syndrome

P. Ravaud, X. Mariette, R. Seror, 2011 .

Reply to J. Magalon et al.

A. Gabrielli, L. Beretta, C. Vitali, 2015, Cell transplantation.

SP0190 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJöGREN”S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES

X. Mariette, Y. Shoenfeld, S. Bombardieri, 2019, Speaker Abstracts.

Renal involvement in primary Sjögren's syndrome: a retrospective-prospective study.

S. Bombardieri, C. Vitali, A. Tavoni, 1991, Scandinavian journal of rheumatology.

Shrinking lung in primary Sjögren's syndrome.

G. Stampacchia, S. Bombardieri, C. Vitali, 1999, Arthritis and rheumatism.

Multicentric Castleman's disease in a patient with primary Sjögren's syndrome

P. Baglioni, S. Bombardieri, C. Vitali, 1992, Rheumatology International.

Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia.

C. Vitali, E. Tsianos, R. Neri, 1992, Clinical and experimental rheumatology.

Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.

C. Vitali, A. Cortelezzi, N. Del Papa, 2008, The Journal of rheumatology.

On focal lymphocytic sialadenitis as a gold standard for the diagnosis of Sjögren's syndrome: comment on the article by Daniels and Whitcher.

S. Bombardieri, C. Vitali, 1995, Arthritis and rheumatism.

HLA antigens in Italian patients with primary Sjögren's syndrome.

S. Bombardieri, C. Vitali, A. D'ascanio, 1986, Annals of the rheumatic diseases.

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

D. Isenberg, M. Snaith, M. Ehrenfeld, 1993, Arthritis and rheumatism.

EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

G. Baron, P. Ravaud, X. Mariette, 2009, Annals of the rheumatic diseases.

Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index

G. Baron, P. Ravaud, X. Mariette, 2010, Arthritis care & research.

NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity

G. Valentini, C. Vitali, D. Sambataro, 2019, Arthritis Research & Therapy.

Chapter 4 – Classification Criteria for Sjögren’s Syndrome

C. Vitali, 2016 .

The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus

S. Bombardieri, W. Bencivelli, C. Vitali, 2000, Lupus.

International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.

S. Bombardieri, A. Doria, A. Tincani, 1996, Clinical and experimental rheumatology.

Chapter 7 Digestive Involvement in Primary Sjögren's Syndrome

E. Theander, C. Vitali, A. Tzioufas, 2008 .

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study

R. Jonsson, D. Isenberg, U. Dafni, 2002, Annals of the rheumatic diseases.

[The imaging diagnosis of Sjögren's syndrome: echography, sialography and scintigraphy compared in the study of the salivary glands].

E. Neri, S. Bonaretti, C. Vitali, 1996, Minerva stomatologica.

Parotid sialography and lip biopsy in the evaluation of oral component in Sjögren's syndrome.

S. Bombardieri, C. Vitali, A. Tavoni, 1989, Clinical and experimental rheumatology.

The Professionals ’ Resource on Sjögren ’ s Syndrome First Genetic Associations Established for Sjögren ’ s

Theresa L. Ford, X. Mariette, N. Stahl, 2014 .

L. Criswell, C. Shiboski, X. Mariette, 2017, Arthritis & rheumatology.

Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK.

R. Jonsson, S. Pillemer, C. Vitali, 2001, Rheumatology.

Chronic myeloid leukemia in Waldenström's macroglobulinemia.

S. Bombardieri, C. Vitali, G. Spremolla, 1981, Archives of internal medicine.

Management of Sjögren's Syndrome: Present Issues and Future Perspectives

C. Vitali, N. Del Papa, A. Minniti, 2021, Frontiers in Medicine.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

Philippe Ravaud, Hendrika Bootsma, Athanasios Tzioufas, 2015, RMD Open.

Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome

S. Bombardieri, C. Vitali, C. Baldini, 2011 .

Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome.

C. Vitali, G. Magazzù, G. di Pasquale, 1999, The Journal of rheumatology.

A plasma cell granuloma in a patient with Sjögren's syndrome.

G. Viegi, S. Bombardieri, C. Vitali, 1985, The Journal of rheumatology.

EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies

X. Mariette, Y. Shoenfeld, S. Bombardieri, 2019, Annals of the rheumatic diseases.

Evaluation of s-adenosylmethionine in primary fibromyalgia: A double-blind crossover study

G. Pasero, S. Bombardieri, C. Vitali, 1987 .

Giant cell arteritis of the leg in a patient with hepatitis C virus infection

C. Vitali, S. Marchi, E. Ciancia, 1997, Annals of the rheumatic diseases.

High prevalence of fragility vertebral fractures in patients hospitalised in Internal Medicine Units. Results of the POINT (Prevalence of Osteoporosis in INTernal medicine) study.

C. Albanese, G. Gussoni, M. Campanini, 2015, Bone.

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

G. Baron, P. Ravaud, X. Mariette, 2014, Annals of the rheumatic diseases.

Multiple and reversible osteolytic lesions: an unusual manifestation of behcet's disease.

C. Vitali, G. Porciello, D. Trippi, 1996, The Journal of rheumatology.

Concomitant ankylosing spondylitis and DISH.

I. Olivieri, G. Pasero, C. Vitali, 1989, The Journal of rheumatology.

Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis

S. Harari, R. Caporali, C. Vitali, 2020, Therapeutic advances in musculoskeletal disease.

Tumoural calcinosis of the spine in the course of systemic sclerosis : report of a new case and review of the literature

C. Vitali, D. Sambataro, G. Sambataro, 2015 .

Urticaria/arthritis syndrome: report of four B51 positive patients.

I. Olivieri, G. Pasero, C. Vitali, 1989, Annals of the rheumatic diseases.

Criteria for the classification of primary fibromyalgia syndrome (fibrositis): an unsolved problem.

C. Vitali, A. Taroni, 1989, Clinical and experimental rheumatology.

Long Non-Coding RNAs Modulate Sjögren’s Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease

C. Vitali, N. Del Papa, E. Tinazzi, 2019, Journal of clinical medicine.

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies

G. Baron, P. Ravaud, X. Mariette, 2016, Annals of the rheumatic diseases.

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

P. Ravaud, X. Mariette, E. Theander, 2014, Annals of the rheumatic diseases.

Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia.

S. Bombardieri, C. Vitali, A. Tavoni, 1989, The American journal of medicine.

Ophthalmological and neuro-ophthalmological involvement in Churg-Strauss syndrome: a case report

M. Nardi, C. Vitali, F. Genovesi-Ebert, 1996, Graefe's Archive for Clinical and Experimental Ophthalmology.

FRI0421 Development of Clinessdai Score (Clinical Eular Sjögren's Syndrome Disease Activity Index) Without Biological Domain: A Tool For Biological Studies

P. Ravaud, X. Mariette, E. Theander, 2015 .

Outcome measures for primary Sjögren's syndrome: a comprehensive review.

P. Ravaud, X. Mariette, E. Theander, 2014, Journal of autoimmunity.

Precocious intima-media thickening in patients with primary Sjögren's syndrome.

E. Mannarino, Y. Shoenfeld, E. Bocci, 2005, Arthritis and rheumatism.

International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.

S. Bombardieri, A. Doria, A. Tincani, 1996, Clinical and experimental rheumatology.

Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients.

S. Bombardieri, R. Priori, G. Valesini, 2007, Arthritis and rheumatism.

Sjögren's syndrome, mixed cryoglobulinaemia and the monoclonal gammopathies.

S. Bombardieri, C. Vitali, 1996, Clinical and experimental rheumatology.

Outcome measures for primary Sjögren's syndrome.

P. Ravaud, X. Mariette, E. Theander, 2012, Journal of autoimmunity.

Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression.

G. Pasero, S. Bombardieri, C. Vitali, 1989, Scandinavian journal of rheumatology.

AB0125 EXPRESSION OF INTERFERON TYPE I- AND TYPE II-INDUCED GENES IN PATIENTS WITH SJÖGREN’S SYNDROME WITH AND WITHOUT EXTRAGLANDULAR INVOLVEMENT

R. Caporali, C. Vitali, N. Papa, 2020 .

Corrigendum: Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements [Rheumatology, 54, (2015) (2230-2238)] DOI: 10.1093/rheumatology/kev200

X. Mariette, E. Theander, S. Bombardieri, 2017 .

Plasma exchange in the treatment of lupus nephritis.

S. Bombardieri, P. Migliorini, C. Vitali, 1983, International Journal of Artificial Organs.

Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome

R. Caporali, C. Vitali, N. Del Papa, 2021, Biomolecules.

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations

C. Vitali, N. Del Papa, A. Minniti, 2019, ACR open rheumatology.

Activity criteria in systemic lupus erythematosus.

S. Bombardieri, W. Bencivelli, C. Vitali, 1994, Clinical and Experimental Rheumatology.

Evidence of neuromuscular hyperexcitability features in patients with primary fibromyalgia.

G. Pasero, C. Giannini, C. Vitali, 1989, Clinical and Experimental Rheumatology.

EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

G. Baron, P. Ravaud, X. Mariette, 2009, Annals of the rheumatic diseases.

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations

C. Vitali, N. Del Papa, A. Minniti, 2018, ACR Open Rheumatology.

Diagnostic criteria for Sjögren's syndrome: the state of the art.

S. Bombardieri, C. Vitali, 1990, Clinical and Experimental Rheumatology.

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sj € ogren’s Syndrome A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts

L. Criswell, C. Shiboski, S. Shiboski, 2016 .

FRI0303 Validation of eular primary sjögren’s syndrome disease activity and patient indexes

P. Ravaud, X. Mariette, E. Theander, 2012 .

OP0217 Defining Disease Activity Sates and Minimal Clinically Important Improvement (MCII) with the EULAR Primary SjÖGren's Syndrome Disease Activity Index (ESSDAI)

P. Ravaud, X. Mariette, E. Theander, 2014 .

Immunotherapy in Rheumatoid Arthritis: A Review

S. Bombardieri, C. Vitali, M. Bombardieri, 1993, The International journal of artificial organs.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

R. Jonsson, S. Pillemer, S. Bombardieri, 2002, Annals of the rheumatic diseases.

Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia.

S. Bombardieri, C. Vitali, C. Ferri, 1994, British journal of rheumatology.

University of Birmingham Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis

Gianluca, Y. Shoenfeld, M. Chimenti, 2018 .

The diagnosis of Sjögren's syndrome: definition and validation of classification criteria for this disorder.

S. Bombardieri, C. Vitali, 1998, Annales de medecine interne.

Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.

F. Ingegnoli, C. Vitali, A. Cortelezzi, 2004, Arthritis and rheumatism.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study.

C. Albanese, G. Gussoni, M. Campanini, 2017, Bone.

[Clotiazepam vs flunitrazepam in premedication in a day hospital regimen].

C. Vitali, A. Riva, M. Bonazzi, 1987, Minerva anestesiologica.

Apical vertebral derotation and translation (AVDT) for adolescent idiopathic scoliosis using screws and sublaminar bands: a safer concept for deformity correction

C. Vitali, B. Misaggi, M. Ferraro, 2018, European Spine Journal.

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations

C. Vitali, N. Del Papa, A. Minniti, 2018, ACR open rheumatology.

NeutraSal ® is clinically proven to help restore the oral environment 2 FOR PATIENTS WITH SJÖGREN ’ S SYNDROME 90 % OF PATIENTS REPORTED IMPROVEMENT IN SWALLOWING

Theresa L. Ford, R. Jonsson, J. Clayton, 2017 .